Net Cash Provided by (Used in) Financing Activities of NOVAVAX INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
NOVAVAX INC annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • NOVAVAX INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $7,061,000, a 220% decline year-over-year.
  • NOVAVAX INC annual Net Cash Provided by (Used in) Financing Activities for 2025 was $27,737,000, a 89% decline from 2024.
  • NOVAVAX INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was $260,583,000, a 5735% increase from 2023.
  • NOVAVAX INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $4,466,000, a 99% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

NOVAVAX INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $27,737,000 -$232,846,000 -89% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $260,583,000 +$256,117,000 +5735% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $4,466,000 -$320,522,000 -99% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $324,988,000 -$136,725,000 -30% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $461,713,000 -$523,049,000 -53% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $984,762,000 +$886,378,000 +901% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $98,384,000 -$4,421,000 -4.3% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $102,805,000 +$38,265,000 +59% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 $64,540,000 -$215,309,000 -77% 01 Jan 2017 31 Dec 2017 10-K 11 Mar 2020 2019 FY
2016 $279,849,000 +$71,566,000 +34% 01 Jan 2016 31 Dec 2016 10-K 18 Mar 2019 2018 FY
2015 $208,283,000 01 Jan 2015 31 Dec 2015 10-K 14 Mar 2018 2017 FY
2012 $53,786,000 +$42,657,000 +383% 01 Jan 2012 31 Dec 2012 10-K 12 Mar 2013 2012 FY
2011 $11,129,000 -$12,300,000 -52% 01 Jan 2011 31 Dec 2011 10-K 12 Mar 2013 2012 FY
2010 $23,429,000 01 Jan 2010 31 Dec 2010 10-K 12 Mar 2013 2012 FY

NOVAVAX INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $7,061,000 -$12,947,000 -220% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $5,886,000 +$360,265,000 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $354,379,000 -$514,244,000 -322% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q1 2022 $159,865,000 -$417,122,000 -72% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $576,987,000 +$391,064,000 +210% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2020 $185,923,000 +$129,742,000 +231% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $56,181,000 +$12,257,000 +28% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q1 2018 $43,924,000 +$28,560,000 +186% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019 2019 Q1
Q1 2017 $15,364,000 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
Q1 2014 $1,170,000 -$6,011,000 -84% 01 Jan 2014 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q1 2013 $7,181,000 -$78,000 -1.1% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q1 2012 $7,259,000 +$5,906,000 +437% 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013 2013 Q1
Q1 2011 $1,353,000 01 Jan 2011 31 Mar 2011 10-Q 09 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.